OXFORD GLYCOSCIENCES UK LTD has a total of 418 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are PROTEOSYS AG, TSS BIOTECH INC and HUDSON INSTITUTE OF MEDICAL RES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 148 | |
#2 | WIPO (World Intellectual Property Organization) | 76 | |
#3 | Australia | 71 | |
#4 | EPO (European Patent Office) | 51 | |
#5 | United States | 19 | |
#6 | Canada | 17 | |
#7 | South Africa | 8 | |
#8 | Israel | 7 | |
#9 | China | 5 | |
#10 | Mexico | 4 | |
#11 | Norway | 3 | |
#12 | Brazil | 2 | |
#13 | New Zealand | 2 | |
#14 | Poland | 2 | |
#15 | Hong Kong | 1 | |
#16 | Hungary | 1 | |
#17 | Indonesia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Heterocyclic compounds | |
#6 | Measuring microorganism processes | |
#7 | Sugars | |
#8 | Chemical or physical processes | |
#9 | Enzymes | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Parekh Rajesh Bhikhu | 65 |
#2 | Terrett Jonathan Alexander | 58 |
#3 | Herath Herath Mudiyanselage At | 40 |
#4 | Rohlff Christian | 36 |
#5 | Townsend Robert Reid | 28 |
#6 | Courtney Stephen Martin | 25 |
#7 | Tyson Kerry Louise | 24 |
#8 | Boyd Robert Simon | 23 |
#9 | Stamps Alasdair Craig | 22 |
#10 | Orchard Michael Glen | 20 |
Publication | Filing date | Title |
---|---|---|
US2010015152A1 | Diagnostic and therapeutic methods | |
AU2005218046A1 | Use of breast cancer associated membrane proteins (BCMP) for treatment, prophylaxis and diagnosis of breast cancer | |
WO2004067480A2 | Substituted phenylurea derivatives as hdac inhibitors | |
AU2003283597A1 | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors | |
AU2003265867A8 | A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use | |
GB0319542D0 | Novel compounds | |
WO2004007454A1 | Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase | |
AU2003254433A1 | Nephrotoxicity marker fumarylacetoacetase | |
AU2003281287A1 | Toxicity markers | |
GB0313924D0 | Protein-Protein interactions | |
GB0313922D0 | Protein-Protein Interactions | |
GB0313923D0 | Protein-protein interactions | |
GB0313678D0 | Novel compounds | |
GB0313677D0 | Novel compound | |
GB0313679D0 | Novel compounds | |
GB0313674D0 | Novel compounds | |
AU2003227861A1 | Protein involved in cancer | |
GB0308327D0 | A protein involved in cancer | |
AU2003222606A8 | Diagnosis of carcinoma using raigi polypeptides | |
AU2003208472A1 | Novel b-cell malignancy-associated protein |